Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | GM | TSLA |
|---|---|---|
| Price | $81.74 | $379.79 |
| Change today | ▼ 2.42% | ▼ 0.09% |
| Market cap | $71.72B | $1.50T |
| Return, 3 months | +3.7% | +1.1% |
| Return, year to date | +1.2% | -15.5% |
| Return, 1 year | +37.6% | -14.2% |
| P/E (TTM) | 36.5 | 351.7 |
| P/B | 1.2 | 17.3 |
| P/E percentile vs own 5y | 98th | 86th |
| Dividend yield | 0.81% | – |
| Revenue growth (YoY, latest qtr) | +1.9% | +25.5% |
| Net profit growth (YoY) | -28.5% | -5.2% |
| Gross margin | 5.7% | 18.9% |
| Operating margin | 1.0% | 4.6% |
| Net margin | 1.0% | 3.7% |
| Return on equity | 2.9% | 4.6% |
| Analyst target vs. price | +30.4% | +5.9% |
| Analyst buy share | 94% | 46% |
| RSI (14) | 46 | 60 |
| 30-day volatility | 30.2% | 44.2% |
| Max drawdown, 1 year | -16.0% | -39.1% |
| Trend read | Leaning bearish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.